Olga V. Naidenko

Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers

Jennifer L. Matsuda, Olga V. Naidenko, Laurent Gapin et al. · The Journal of Experimental Medicine · 2000 · 880 citations · Full text

Life Sciences, Cell Biology, Immunology +13

Recognition of a virus-encoded ligand by a natural killer cell activation receptor

Hamish R.C. Smith, Jonathan W. Heusel, Indira K. Mehta et al. · Proceedings of the National Academy of Sciences · 2002 · 754 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

Shayan Sharif, Guillermo Arreaza, Peter Zucker et al. · Nature Medicine · 2001 · 599 citations

Life Sciences, Endocrinology, Immunology +11

The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

Seokmann Hong, Michael T. Wilson, Isao Serizawa et al. · Nature Medicine · 2001 · 546 citations

Life Sciences, Endocrinology, Immunology +11

Human NKT Cells Mediate Antitumor Cytotoxicity Directly by Recognizing Target Cell CD1d with Bound Ligand or Indirectly by Producing IL-2 to Activate NK Cells

Leonid S. Metelitsa, Olga V. Naidenko, Anita Kant et al. · The Journal of Immunology · 2001 · 359 citations

Life Sciences, Immunology, Oncology +11